FIRM FIXED PRICESMALL BUSINESS SET ASIDE - TOTAL

PERFUSION MEDICAL LLC - RESEARCH AND DEVELOPMENT OF OPTIMAL DOSING AND FORMULATION OF PM-208 (PEG-20K/8K) FOR AF FIELD USE

PIID: FA864924P0552

Signed Date: Nov 18, 2025Effective Date: Feb 9, 2024End Date: Closed on Apr 7, 2026

Award $

$1.8M

Vendor

PERFUSION MEDICAL LLC

NAICS

541715

Signed Date

Nov 18, 2025

Key Details

Dollars Obligated

$1.8M

Base & All Options

Awarding Agency

Awarding Sub-Agency

Department of the Air Force

NAICS Code

Product Service Code

AC32 - NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Number of Offers

Place of Performance

HERNDON, VA, 201714058, CD-VA-11

RESEARCH AND DEVELOPMENT OF OPTIMAL DOSING AND FORMULATION OF PM-208 (PEG-20K/8K) FOR AF FIELD USE

On Nov 18, 2025, Department of Defense obligated $1,799,322 to PERFUSION MEDICAL LLC for research and development of optimal dosing and formulation of pm-208 (peg-20k/8k) for af field use. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 84 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in HERNDON, VA.